Licensed in both the Kentucky Bar and the State Bar of California with a seat on the national Essure medical-device Steering Committee, Schmidt National Law Group runs its mass-tort, class-action, and pharmaceutical-injury docket from 3033 Fifth Ave Suite 335 in Hillcrest, 92103, offering Italian- and Spanish-language intake. Mass-tort settlements usually arrive as structured or lump-sum payouts with complex 1099 and basis-allocation issues, and post-settlement tax planning gets handed off to outside CPAs — Chakarian & Associates Inc has handled client allocations from prior Schmidt recoveries. The docket runs through defective-pharmaceutical actions, implantable-device cases, corporate-fraud claims, and employment-violation class actions against large corporate defendants, exclusively on a no-fee-unless-recovered contingency basis. Seven-figure mass-tort recoveries require structured-settlement annuity planning before disbursement, and Financial Haus has fielded several post-settlement intakes so special-needs trusts and Medicare set-asides are funded before the check clears. The firm's most complex work couples multi-district federal mass-tort litigation against pharmaceutical manufacturers with parallel state-court individual cases, bellwether trial selection, and cross-jurisdictional settlement allocation across thousands of plaintiff claimants.